Remedios Quirce
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Remedios Quirce has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
I. Banzo
Nuclear Medicine and Molecular Imaging Service, University Hospital "Marqués de Valdecilla", University of Cantabria, Santander, Spain
3 shared publicationsI. Martínez-Rodríguez
Servicio de Medicina Nuclear, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Cantabria, Spain
3 shared publicationsJ.F. Jiménez-Bonilla
Servicio de Medicina Nuclear, Hospital Universitario “Marqués de Vadecilla”, Universidad de Cantabria, Santander, Spain
3 shared publicationsJ.M. Carril
Servicio de Medicina Nuclear, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Cantabria, Spain
3 shared publicationsA. Rubio-Vassallo
Servicio de Medicina Nuclear, Hospital Universitario “Marqués de Vadecilla”, Universidad de Cantabria, Santander, Spain
2 shared publicationsE. Palacio
Servicio de Neurología, Hospital Universitario “Marqués de Vadecilla”, Universidad de Cantabria, Santander, Spain
2 shared publications
Latest Publications
- Open Access
- 30 September 2016
- Published by MDPI AG in Diagnostics
- Vol. 6 (4) , 36
The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide and its prognosis remains poor. Molecular imaging with 18F-FDG PET/CT can metabolically characterize the nature of lesions as benign or malignant, allowing a better staging at the diagnosis of this kind of patient. This advantage can also be applied in the re-staging due to the suspicion of recurrent disease. Many patients have a recurrence of the disease, including surgically treated patients. In the current context, with new personalized oncological treatments, the surveillance for recurrence and its accurate diagnosis are crucial to improve their survival. In this paper, we revise the current knowledge about the clinical and molecular factors related to the recurrent disease. In the context of new, promising, available personalized treatments, the role of molecular imaging with PET/CT and 18F-FDG and non-18F-FDG radiotracers in the follow-up of NSCLC-treated patients is especially attractive and interesting.
- 30 September 2016
- Published by MDPI AG in Diagnostics
- Vol. 6 (4) , 36
Open AccessThe Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide and its prognosis remains poor. Molecular imaging with 18F-FDG PET/CT can metabolically characterize the nature of lesions as benign or malignant, allowing a better staging at the diagnosis of this kind of patient. This advantage can also be applied in the re-staging due to the suspicion of recurrent disease. Many patients have a recurrence of the disease, including surgically treated patients. In the current context, with new personalized oncological treatments, the surveillance for recurrence and its accurate diagnosis are crucial to improve their survival. In this paper, we revise the current knowledge about the clinical and molecular factors related to the recurrent disease. In the context of new, promising, available personalized treatments, the role of molecular imaging with PET/CT and 18F-FDG and non-18F-FDG radiotracers in the follow-up of NSCLC-treated patients is especially attractive and interesting.
- 3 July 2015
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 36 (6) , 499-503
New insight of functional molecular imaging into the atheroma biology: 18F‐NaF and 18F‐FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results
Summary: Aim: The identification of the vulnerable atheroma plaque could allow a more effective treatment of cerebrovascular accident (CVA). Active calcification and inflammation of the carotid atheroma were assessed and compared in symptomatic and asymptomatic plaques by 18F‐NaF and 18F‐FDG PET/CT.Methods: Nine patients investigated for recent CVA and no preventive treatment with statins were enrolled. In each patient, at least one atheroma plaque was detected by CT angiogram. In total, 18 plaques were available: 9 symptomatic and 9 asymptomatic. 18F‐NaF uptake and 18F‐FDG uptake by each plaque were assessed visually and semiquantitatively by calculating target/background ratios (TBRs) and TBR indexes (TBR symptomatic/TBR asymptomatic and 18F‐NaF TBR/18F‐FDG TBR within each of the 2 clinical groups of plaques).Results: All plaques showed 18F‐NaF and 18F‐FDG uptake, and semiquantitation showed higher 18F‐NaF uptake by 11 of the 18 plaques, 6 symptomatic and 5 asymptomatic. In the symptomatic group, the mean 18F‐NaF TBR was 2·12 ± 0·44, and in the asymptomatic group, it was 1·85 ± 0·46. The 18F‐NaF/18F‐FDG showed that, overall, 18F‐NaF uptake is higher than 18F‐FDG. In the symptomatic plaques, the 18F‐NaF was higher for the low calcium content and the lowest for the high.Conclusion: Active calcification and inflammation are simultaneous processes in the symptomatic and asymptomatic carotid atheroma. However, active calcification seems predominant over inflammation in both groups. In the symptomatic plaques, the highest 18F‐NaF uptake does not correspond with the largest calcium content. These patterns open new insights on the role of 18F‐NaF in the study of calcification and in the identification of the vulnerable carotid atheroma.
- 3 July 2015
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 36 (6) , 499-503
New insight of functional molecular imaging into the atheroma biology: 18F‐NaF and 18F‐FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results
Summary: Aim: The identification of the vulnerable atheroma plaque could allow a more effective treatment of cerebrovascular accident (CVA). Active calcification and inflammation of the carotid atheroma were assessed and compared in symptomatic and asymptomatic plaques by 18F‐NaF and 18F‐FDG PET/CT.Methods: Nine patients investigated for recent CVA and no preventive treatment with statins were enrolled. In each patient, at least one atheroma plaque was detected by CT angiogram. In total, 18 plaques were available: 9 symptomatic and 9 asymptomatic. 18F‐NaF uptake and 18F‐FDG uptake by each plaque were assessed visually and semiquantitatively by calculating target/background ratios (TBRs) and TBR indexes (TBR symptomatic/TBR asymptomatic and 18F‐NaF TBR/18F‐FDG TBR within each of the 2 clinical groups of plaques).Results: All plaques showed 18F‐NaF and 18F‐FDG uptake, and semiquantitation showed higher 18F‐NaF uptake by 11 of the 18 plaques, 6 symptomatic and 5 asymptomatic. In the symptomatic group, the mean 18F‐NaF TBR was 2·12 ± 0·44, and in the asymptomatic group, it was 1·85 ± 0·46. The 18F‐NaF/18F‐FDG showed that, overall, 18F‐NaF uptake is higher than 18F‐FDG. In the symptomatic plaques, the 18F‐NaF was higher for the low calcium content and the lowest for the high.Conclusion: Active calcification and inflammation are simultaneous processes in the symptomatic and asymptomatic carotid atheroma. However, active calcification seems predominant over inflammation in both groups. In the symptomatic plaques, the highest 18F‐NaF uptake does not correspond with the largest calcium content. These patterns open new insights on the role of 18F‐NaF in the study of calcification and in the identification of the vulnerable carotid atheroma.
- 1 May 2014
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 33 (3) , 153-158
Contribution of V/Q SPECT to planar scintigraphy in the diagnosis of pulmonary embolism
- 1 May 2014
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 33 (3) , 153-158
Contribution of V/Q SPECT to planar scintigraphy in the diagnosis of pulmonary embolism
- 1 June 2013
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 38 (6) , 451-452
New Insight of Molecular Imaging Into the Atheroma Biology
In a 75-year-old patient admitted with a middle cerebral artery stroke, a contrast-enhanced CT showed 3 atheroma plaques. Five days after the stroke, a F-fluoride PET/CT to evaluate calcification and, 24 hours later, a F-FDG PET/CT to evaluate inflammation were carried out. The different metabolic behavior of both radiotracers, showing different intensities and distribution in each plaque, may represent different phases of the atherogenesis and in combination could provide new information for the early identification of the carotid unstable plaque.
- 1 June 2013
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 38 (6) , 451-452
New Insight of Molecular Imaging Into the Atheroma Biology
In a 75-year-old patient admitted with a middle cerebral artery stroke, a contrast-enhanced CT showed 3 atheroma plaques. Five days after the stroke, a F-fluoride PET/CT to evaluate calcification and, 24 hours later, a F-FDG PET/CT to evaluate inflammation were carried out. The different metabolic behavior of both radiotracers, showing different intensities and distribution in each plaque, may represent different phases of the atherogenesis and in combination could provide new information for the early identification of the carotid unstable plaque.
- 28 February 2013
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
- Vol. 32 (1) , 22-25
Contribution of 18F-sodium fluoride PET/CT to the study of the carotid atheroma calcification
- 28 February 2013
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
- Vol. 32 (1) , 22-25
Contribution of 18F-sodium fluoride PET/CT to the study of the carotid atheroma calcification
- 1 January 2013
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 32 (1) , 22-25
Contribution of 18F-sodium fluoride PET/CT to the study of the carotid atheroma calcification
- 1 January 2013
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 32 (1) , 22-25
Contribution of 18F-sodium fluoride PET/CT to the study of the carotid atheroma calcification
- 30 April 2008
- Published by Elsevier in Revista Española de Medicina Nuclear
- Vol. 27 (2) , 130-159
Potenciales fuentes de error diagnóstico y variantes de la FDG-PET/TAC
- 30 April 2008
- Published by Elsevier in Revista Española de Medicina Nuclear
- Vol. 27 (2) , 130-159
Potenciales fuentes de error diagnóstico y variantes de la FDG-PET/TAC
- 1 May 2002
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 23 (5) , 453-459
Assessment of the diagnostic capacity of planar scintigraphy and SPECT with 99mTc-HMPAO-labelled leukocytes in superficial and deep sternal infections after median sternotomy
Sternal infection is a rare complication of median sternotomy but is associated with considerable morbidity and mortality, particularly in the case of deep sternal infection (mediastinitis). Successful treatment depends on early diagnosis and on the location (deep or superficial) of the infection. Radiological techniques have many limitations, and although 67Ga scintigraphy is effective, it delays diagnosis by 48 h. We assessed the diagnostic capacity of planar scintigraphy and single photon emission computed tomography (SPECT) with 99mTc-hexamethylpropylene amine oxime (HMPAO)-labelled leukocytes in deep sternal infections after median sternotomy. We prospectively studied 41 patients with clinical suspicion of deep sternal infection 4 and 20 h after administration of the tracer. The final diagnosis was deep sternal infection in nine patients and superficial sternal infection in 10, with infection being ruled out in 22 patients. Planar scintigraphy did not detect any of the deep sternal infections at either 4 h or 20 h. SPECT correctly identified eight of the nine deep sternal infections at 4 h and all seven at 20 h, with no false positive results. Planar scintigraphy identified 16 of the 18 superficial sternal infections at 4 h and all of them at 20 h. SPECT identified 17 of these 18 infections at 4 h and all of them at 20 h. Other infections unrelated to the sternotomy were identified in seven patients. Leukocytes labelled with 99mTc-HMPAO are a highly reliable method for the early diagnosis of sternal infections after median sternotomy. Use of SPECT allows determination of the depth of the infection and differentiation of superficial from deep sternal infections. It is also possible to detect other sites of infection, thus providing alternative diagnoses.
- 1 May 2002
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 23 (5) , 453-459
Assessment of the diagnostic capacity of planar scintigraphy and SPECT with 99mTc-HMPAO-labelled leukocytes in superficial and deep sternal infections after median sternotomy
Sternal infection is a rare complication of median sternotomy but is associated with considerable morbidity and mortality, particularly in the case of deep sternal infection (mediastinitis). Successful treatment depends on early diagnosis and on the location (deep or superficial) of the infection. Radiological techniques have many limitations, and although 67Ga scintigraphy is effective, it delays diagnosis by 48 h. We assessed the diagnostic capacity of planar scintigraphy and single photon emission computed tomography (SPECT) with 99mTc-hexamethylpropylene amine oxime (HMPAO)-labelled leukocytes in deep sternal infections after median sternotomy. We prospectively studied 41 patients with clinical suspicion of deep sternal infection 4 and 20 h after administration of the tracer. The final diagnosis was deep sternal infection in nine patients and superficial sternal infection in 10, with infection being ruled out in 22 patients. Planar scintigraphy did not detect any of the deep sternal infections at either 4 h or 20 h. SPECT correctly identified eight of the nine deep sternal infections at 4 h and all seven at 20 h, with no false positive results. Planar scintigraphy identified 16 of the 18 superficial sternal infections at 4 h and all of them at 20 h. SPECT identified 17 of these 18 infections at 4 h and all of them at 20 h. Other infections unrelated to the sternotomy were identified in seven patients. Leukocytes labelled with 99mTc-HMPAO are a highly reliable method for the early diagnosis of sternal infections after median sternotomy. Use of SPECT allows determination of the depth of the infection and differentiation of superficial from deep sternal infections. It is also possible to detect other sites of infection, thus providing alternative diagnoses.